Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
Related Research units
Abstract
Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding feasibility, safety and perioperative outcome of these often complex procedures is limited.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 6 |
| ISSN | 0748-7983 |
| Publication status | Published - 2010 |
| pubmed | 20488646 |
|---|
